These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34960805)
61. Quasispecies, error catastrophe, and the antiviral activity of ribavirin. Graci JD; Cameron CE Virology; 2002 Jul; 298(2):175-80. PubMed ID: 12127780 [TBL] [Abstract][Full Text] [Related]
62. Generation and propagation of recombinant mumps viruses exhibiting an additional U residue in the homopolymeric U tract of the F gene-end signal. Sauder CJ; Ngo L; Simonyan V; Cong Y; Zhang C; Link M; Malik T; Rubin SA Virus Genes; 2015 Aug; 51(1):12-24. PubMed ID: 25962759 [TBL] [Abstract][Full Text] [Related]
65. Mutagen resistance and mutation restriction of St. Louis encephalitis virus. Griesemer SB; Kramer LD; Van Slyke GA; Pata JD; Gohara DW; Cameron CE; Ciota AT J Gen Virol; 2017 Feb; 98(2):201-211. PubMed ID: 28284278 [TBL] [Abstract][Full Text] [Related]
66. Establishment of an efficient reverse genetic system of Mumps virus S79 from cloned DNA. Zhou D; Zhu MY; Wang YL; Hao XQ; Zhou DM; Liu RX; Zhang CD; Qu CF; Zhao ZY World J Pediatr; 2019 Oct; 15(5):499-505. PubMed ID: 31456156 [TBL] [Abstract][Full Text] [Related]
67. In vitro and in vivo activity of ribavirin against Andes virus infection. Safronetz D; Haddock E; Feldmann F; Ebihara H; Feldmann H PLoS One; 2011; 6(8):e23560. PubMed ID: 21853152 [TBL] [Abstract][Full Text] [Related]
68. Functional Characterization of Circulating Mumps Viruses with Stop Codon Mutations in the Small Hydrophobic Protein. Stinnett RC; Beck AS; Lopareva EN; McNall RJ; Latner DR; Hickman CJ; Rota PA; Bankamp B mSphere; 2020 Nov; 5(6):. PubMed ID: 33208518 [TBL] [Abstract][Full Text] [Related]
69. A single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence in vivo. Malik T; Sauder C; Wolbert C; Zhang C; Carbone KM; Rubin S J Neurovirol; 2007 Dec; 13(6):513-21. PubMed ID: 18097883 [TBL] [Abstract][Full Text] [Related]
70. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Sauder CJ; Vandenburgh KM; Iskow RC; Malik T; Carbone KM; Rubin SA Virology; 2006 Jun; 350(1):48-57. PubMed ID: 16494912 [TBL] [Abstract][Full Text] [Related]
71. An efficient, reproducible and accurate RT-qPCR based method to determine mumps specific neutralizing antibody. Sikazwe CT; Levy A; Speers D; Smith DW J Virol Methods; 2020 Mar; 277():113817. PubMed ID: 31911119 [TBL] [Abstract][Full Text] [Related]
72. Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs. Mihalik KB; Feigelstock DA PLoS One; 2013; 8(9):e74027. PubMed ID: 24040153 [TBL] [Abstract][Full Text] [Related]
73. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models. Kim JA; Seong RK; Kumar M; Shin OS Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176 [TBL] [Abstract][Full Text] [Related]
74. Disruption of the Dimer-Dimer Interaction of the Mumps Virus Attachment Protein Head Domain, Aided by an Anion Located at the Interface, Compromises Membrane Fusion Triggering. Kubota M; Okabe I; Nakakita SI; Ueo A; Shirogane Y; Yanagi Y; Hashiguchi T J Virol; 2020 Jan; 94(2):. PubMed ID: 31619562 [TBL] [Abstract][Full Text] [Related]
75. Complete genome sequence of mumps viruses isolated from patients with parotitis, pancreatitis and encephalitis in India. Vaidya SR; Chowdhury DT; Jadhav SM; Hamde VS Infect Genet Evol; 2016 Apr; 39():272-278. PubMed ID: 26876221 [TBL] [Abstract][Full Text] [Related]
76. Identification and development of a promising novel mumps vaccine candidate strain. Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105 [TBL] [Abstract][Full Text] [Related]
77. Antiviral activity of Ribavirin nano-particles against measles virus. Ahmed EM; Solyman SM; Mohamed N; Boseila AA; Hanora A Cell Mol Biol (Noisy-le-grand); 2018 Jun; 64(9):24-32. PubMed ID: 30030950 [TBL] [Abstract][Full Text] [Related]
78. Cross-Neutralization between Human and African Bat Mumps Viruses. Katoh H; Kubota T; Ihara T; Maeda K; Takeda M; Kidokoro M Emerg Infect Dis; 2016 Apr; 22(4):703-6. PubMed ID: 26982800 [TBL] [Abstract][Full Text] [Related]
79. Effect of change in cell substrate on the critical quality attributes of L-Zagreb Mumps vaccine manufactured using parallel plate bioreactor. Muley R; Dhere R Biologicals; 2020 Sep; 67():29-37. PubMed ID: 32855039 [TBL] [Abstract][Full Text] [Related]
80. Lee MJ; Kim KH; Yi J; Choi SJ; Choe PG; Park WB; Kim NJ; Oh MD Korean J Intern Med; 2017 Jul; 32(4):731-737. PubMed ID: 27899013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]